Insider Transactions in Q1 2025 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2025
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,204
-1.79%
|
$43,344
$36.41 P/Share
|
|
Mar 31
2025
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,106
+5.76%
|
-
|
|
Mar 31
2025
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
744
-1.74%
|
$26,784
$36.41 P/Share
|
|
Mar 31
2025
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,791
+4.02%
|
-
|
|
Mar 04
2025
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,759
-2.71%
|
$54,529
$31.7 P/Share
|
|
Mar 04
2025
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,002
+8.47%
|
-
|